about
Botulinum toxin for shoulder painEmerging opportunities for serotypes of botulinum neurotoxinsTreatment of advanced Parkinson's diseaseComparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective AnalysisEfficacy of biofeedback therapy via a mini wireless device on sleep bruxism contrasted with occlusal splint: a pilot studyBotulinum neurotoxin type A induces TLR2-mediated inflammatory responses in macrophages.Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A.Long-term efficacy and safety of botulinum toxin injections in dystonia.Occurrence of Dysphagia Following Botulinum Toxin Injection in Parkinsonism-related Cervical Dystonia: A Retrospective Study.Camptocormia in Parkinson's disease: a review of the literature.Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.Targeted secretion inhibitors-innovative protein therapeuticsManagement of pain in Parkinson's disease.An update on the use of botulinum toxin therapy in Parkinson's disease.Parkinson's Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options - A Practise Guide.Therapy-resistant symptoms in Parkinson's disease.Management of oromandibular dystonia on a chorea acanthocytosis: a brief review of the literature and a clinical case.Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review.Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson's disease.Flu-like symptoms and associated immunological response following therapy with botulinum toxins.Pharmacological therapies for pain in Parkinson's disease - a review paper.Ultrasound Guidance for Botulinum Neurotoxin Chemodenervation Procedures.The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders.Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.Effectiveness of BoNT A in Parkinson's Disease Upper Limb Tremor Management
P2860
Q24235542-AE249C60-5700-4514-BE39-B46895ED98B7Q26859917-F1B9B1F0-F077-4E57-BB54-E46BA1187833Q30476968-5DA731C8-E80A-4561-A331-A42F912CE692Q34704553-5E1384B2-0F9C-49BD-99B1-57A978F7B607Q35310328-EAEC4DCD-CC67-47B5-8E6C-E8E08A6AE961Q35326849-FC0953B1-0945-461F-AAD2-E876E81DC6EAQ35694486-3CB1026B-1CBB-4972-8988-020C5592E02DQ36807185-C655BCDB-8510-48C4-B42C-C9E9BE7291B3Q37400295-2CCE9BAA-3378-4E99-B505-D2DF9661A6BAQ37851294-B3B04AFD-4C19-48A4-97FA-B13DF5CE2D1BQ37902895-D544DC4A-4B04-4651-BF40-6CF664F88BB6Q37954277-F7622EAD-0738-48C1-9120-44F1F0EF2A45Q38051280-B451B315-053B-4692-B97A-07FF3EC384C1Q38269292-C36E614F-3D13-49B5-8B5E-E75D8EDCF5D8Q38592741-6872D62C-5BA1-4C66-8C67-8E22D7B61F30Q38593798-452F58B0-BD69-4393-A410-EC7E1551C71AQ38597864-414FB6F1-F134-4F75-9964-AE0676EABB2BQ38947256-5B3FC2D8-3B5B-43F9-9B0E-4BA66A09862DQ39264721-00D1F478-8C49-46A1-9AA7-82B09C1A1879Q39440585-96A174D8-BA4C-4A5E-8946-C0A8180045D2Q43736034-E28B2F7A-F92B-4AC2-A8CC-2977A41FF904Q48287781-490CC62A-138C-423E-9B30-78A12649F0ADQ48337621-A0DECA4E-F20E-424E-8BA1-4E3D40C0B24BQ50162598-74A65E13-DFAF-4B87-A629-84CBE95A53F4Q51112226-3EBFE7B6-5B61-4B3C-BAFD-573D01707F5BQ55250949-F2AAE9BD-B9D9-4DD6-B057-E4A22B1E13FCQ58455086-C4A1D981-6944-4334-82CF-23EBA0B234AD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disease-oriented approach to botulinum toxin use.
@en
Disease-oriented approach to botulinum toxin use.
@nl
type
label
Disease-oriented approach to botulinum toxin use.
@en
Disease-oriented approach to botulinum toxin use.
@nl
prefLabel
Disease-oriented approach to botulinum toxin use.
@en
Disease-oriented approach to botulinum toxin use.
@nl
P1433
P1476
Disease-oriented approach to botulinum toxin use.
@en
P304
P356
10.1016/J.TOXICON.2008.11.013
P577
2008-12-06T00:00:00Z